|
⚲
|
| Keyboard |
| KKR Credit Advisors US LLC
✚
|
|
|---|---|
| CRD # | 146629 |
| SEC # | 801-69633 |
| CIK # | 0001520692 |
| AUM | 270.85 B (2026-03-31) |
| Employees | 609 (30% Investors, 9% Brokers) |
| Phone | 415-315-3620 |
| Address | 555 California Street San Francisco, CA 94104 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Instagram] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| BrightSpring Health Services Inc | 1.8 | ||
| Henry Schein Inc | 1.2 | ||
| Bridgebio Pharma Inc | 1.0 | ||
| Crescent Energy Co | 0.4 | ||
| NIQ Global Intelligence PLC | 0.3 | ||
| Brightview Holdings Inc | 0.3 | ||
| KKR Real Estate Finance Trust Inc | 0.1 | ||
| New Pluto Global Inc | 0.0 | ||
| Oxford Lane Capital Corp | 0.0 | ||
| Biovail Corp | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Florida State Board Administration Apalach Partners BL LP | [2026-03-31] | 475.7 M | |
| Filed 2025-04-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Kestrel MCDL I Fund LP | 2026-03-31 | 858.7 M | |
| HF | KKR Enhanced European Direct Lending Fund SCSP | [2026-03-31] | 309.2 M | |
| Filed 2025-07-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | KKR Opportunities Fund III Domestic | [2026-03-31] | 1,119.3 M | 262.5 M |
| Filed 2022-11-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $5,425,000 · Revenue Decline to Disclose | ||||
| HF | KKR Opportunities Fund III EEA | [2026-03-31] | 490.4 M | |
| Filed 2025-09-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | KKR Opportunities Fund III EUR EEA | [2026-03-31] | 88.1 M | |
| Filed 2025-12-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | KKR Sustainable Asset Credit Fund LP | [2026-02-27] | 90.8 M | |
| Filed 2025-07-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Alps Co-Invest LP | 2025-03-31 | ||
| PE | KKR Amethyst Co-Investment LP | 2025-03-31 | 28.3 M | |
| HF | KKR Concentrated Credit Q LP | 2025-03-31 | ||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 5 | 1.9 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 167 | 93.2 |
| (g) Pension and profit sharing plans | 6 | 3.5 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 5 | 1.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 21 | 171.4 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 204 | 270.9 |
| By Discretionary | ||
| Discretionary | 204 | 270.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 204 | 270.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 53.2 | |
| United States Persons | 217.7 | |
| Total | 204 | 270.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jeffrey Smith | Executive Officer | 212 | 8 | |
| Hadi Husain | Executive Officer | 84 | 6 | |
| Nicole Macarchuk | Director, Executive Officer | 73 | 5 | |
| Anthony Davis | Executive Officer | 63 | 5 | |
| William Sonneborn | Director, Executive Officer | 59 | 5 | |
| Daniel Allen | Executive Officer | 46 | 5 | |
| Christopher Denune | Executive Officer | 36 | 5 | |
| Gregory Hall | Director | 181 | 4 | |
| Jeffrey van Horn | Director, Executive Officer | 123 | 4 | |
| Suzanne Donohoe | Executive Officer | 96 | 4 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001520692] | |
| 13F-NT | [0001520692] | |
| 3 | [0001520692] | |
| 4 | [0001520692] | |
| SC 13D | [0001520692] | |
| SC 13G | [0001520692] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $36.6B |
| Serves | Institutional, Research |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 1LNBLO34HQLF73FT3218 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amedisys Inc AMED
Common Stock
|
2018-06-04 | Sell | 2,418,304 | $73.96 | 178,857,764 |
|
Amedisys Inc AMED
Common Stock
|
2018-06-04 | Sell | 19,120 | $73.96 | 1,414,115 |
|
Willbros Group Inc New WG
Common Stock, $0.05 par value
|
2018-06-01 | Other | 10,125,410 | $0.60 | 6,075,246 |
|
Warrior Met Coal Inc HCC
Common Stock
|
2017-04-19 | Sell | 2,389,274 | $17.81 | 42,552,970 |
|
Corporate Capital Trust II NONE
Common Stock, par value $0.001 per share
|
2016-03-01 | Buy | 277,777.78 | $9.00 | 2,500,000 |
|
Amedisys Inc AMED
Common Stock
|
2014-04-01 | Other | 16,639 | $14.89 | 247,755 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-21 | Buy | 80,000 | $14.77 | 1,181,600 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-20 | Buy | 156,917 | $14.39 | 2,258,036 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-19 | Buy | 188,598 | $14.43 | 2,721,469 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-14 | Buy | 165,000 | $13.53 | 2,232,450 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-13 | Buy | 300,000 | $13.37 | 4,011,000 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-12 | Buy | 13,333 | $13.98 | 186,395 |
|
Amedisys Inc AMED
Common Stock
|
2013-11-12 | Buy | 468,167 | $14.36 | 6,722,878 |
|
Amedisys Inc AMED
Common Stock
|
2013-10-30 | Buy | 29,615 | $15.94 | 472,063 |
|
Amedisys Inc AMED
Common Stock
|
2013-10-22 | Buy | 79,626 | $17.75 | 1,413,362 |
|
Amedisys Inc AMED
Common Stock
|
2013-10-21 | Buy | 106,387 | $17.40 | 1,851,134 |
|
Amedisys Inc AMED
Common Stock
|
2013-10-18 | Buy | 2,700 | $17.91 | 48,357 |
|
Amedisys Inc AMED
Common Stock
|
2013-10-17 | Buy | 9,952 | $17.96 | 178,738 |
| Related Firms | State | AUM |
|---|---|---|
|
Kohlberg Kravis Roberts & Co LP
✚
|
NY | 399.90 B |
|
KKR Credit Advisors US LLC
✚
|
CA | 270.85 B |
| Comparable Firms | State | AUM |
|---|---|---|
|
NB Alternatives Advisers LLC
✚
|
TX | 160.24 B |
|
Churchill Asset Management LLC
✚
|
NY | 55.66 B |
|
Leucadia Asset Management LLC
✚
|
NY | 3,056.3 M |
|
Generative Investment Partners LP
✚
|
CT | 293.9 M |
|
The Northern Trust Company of Connecticut
✚
|
CT | |
|
MC Asset Management Holdings LLC
✚
|
CT | |
|
Marshall Wace LLP
✚
|